المؤلفون: Song JG; BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University-Seoul, Goyang, Korea., Baral KC; BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University-Seoul, Goyang, Korea., Kim GL; BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University-Seoul, Goyang, Korea., Park JW; BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University-Seoul, Goyang, Korea., Seo SH; BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University-Seoul, Goyang, Korea., Kim DH; BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University-Seoul, Goyang, Korea., Jung DH; BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University-Seoul, Goyang, Korea., Ifekpolugo NL; BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University-Seoul, Goyang, Korea., Han HK; BK21 FOUR Team and Integrated Research Institute for Drug Development, College of Pharmacy, Dongguk University-Seoul, Goyang, Korea.

المصدر: Drug delivery [Drug Deliv] 2023 Dec; Vol. 30 (1), pp. 2183816.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9417471 Publication Model: Print Cited Medium: Internet ISSN: 1521-0464 (Electronic) Linking ISSN: 10717544 NLM ISO Abbreviation: Drug Deliv Subsets: MEDLINE

مواضيع طبية MeSH: Tandem Mass Spectrometry*, Chromatography, Liquid ; Pharmaceutical Preparations

المؤلفون: Wu ZW; Institute for Vaccine Clinical Research, Hebei Province Center for Disease Control and Prevention, Shijiazhuang, People's Republic of China., Jin F; Institute for Vaccine Clinical Research, Hebei Province Center for Disease Control and Prevention, Shijiazhuang, People's Republic of China., Li QL; National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co., Ltd, Wuhan, People's Republic of China., Gao JM; National Institutes for Food and Drug Control, Beijing, China., Zhou HS; Zhengding County Center for Disease Control and Prevention, Zhengding, People's Republic of China., Duan K; National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co., Ltd, Wuhan, People's Republic of China., Gao Z; Institute for Vaccine Clinical Research, Hebei Province Center for Disease Control and Prevention, Shijiazhuang, People's Republic of China., Liu Y; National Institutes for Food and Drug Control, Beijing, China., Hao ZY; Zhengding County Center for Disease Control and Prevention, Zhengding, People's Republic of China., Chen W; National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co., Ltd, Wuhan, People's Republic of China., Liu YY; National Institutes for Food and Drug Control, Beijing, China., Xu GL; National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co., Ltd, Wuhan, People's Republic of China., Yang B; National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co., Ltd, Wuhan, People's Republic of China., Dong B; National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co., Ltd, Wuhan, People's Republic of China., Zhang JW; National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co., Ltd, Wuhan, People's Republic of China., Zhao YL; Institute for Vaccine Clinical Research, Hebei Province Center for Disease Control and Prevention, Shijiazhuang, People's Republic of China., Yang XM; National Engineering Technology Research Center for Combined Vaccines, Wuhan Institute of Biological Products Co., Ltd, Wuhan, People's Republic of China.

المصدر: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2023 Aug; Vol. 19 (2), pp. 2263228. Date of Electronic Publication: 2023 Oct 16.

نوع المنشور: Randomized Controlled Trial; Clinical Trial, Phase II; Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Rotavirus* , Rotavirus Infections*/prevention & control , Rotavirus Vaccines*/adverse effects , Rotavirus Vaccines*/therapeutic use, Humans ; Infant ; Antibodies, Viral ; Double-Blind Method ; East Asian People ; Immunogenicity, Vaccine ; Immunoglobulin A ; Vaccines, Attenuated ; Vaccines, Combined

المؤلفون: Ye TW; General Surgery, Cancer Center, Department of Hepatobiliary and Pancreatic Surgery and Minimal Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.; The Second School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China., Wang DD; General Surgery, Cancer Center, Department of Hepatobiliary and Pancreatic Surgery and Minimal Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China., Lu WF; Department of Hepatobiliary Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University (Navy Medical University), Shanghai, Zhejiang, China., Xie YM; General Surgery, Cancer Center, Department of Hepatobiliary and Pancreatic Surgery and Minimal Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China., Xu FQ; General Surgery, Cancer Center, Department of Hepatobiliary and Pancreatic Surgery and Minimal Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China., Fu TW; General Surgery, Cancer Center, Department of Hepatobiliary and Pancreatic Surgery and Minimal Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China., Zhang KJ; General Surgery, Cancer Center, Department of Hepatobiliary and Pancreatic Surgery and Minimal Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China., Liu SY; Department of Medical, Lishui Municipal Central Hospital, Lishui, Zhejiang, China., Xie GL; Department of Hepatobiliary Surgery, Affiliated Hospital of Shaoxing University, Shaoxing, Zhejiang, China., Cheng J; General Surgery, Cancer Center, Department of Hepatobiliary and Pancreatic Surgery and Minimal Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China., Jiang K; General Surgery, Cancer Center, Department of Hepatobiliary and Pancreatic Surgery and Minimal Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China., Xiao ZQ; General Surgery, Cancer Center, Department of Hepatobiliary and Pancreatic Surgery and Minimal Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China., Yao WF; General Surgery, Cancer Center, Department of Hepatobiliary and Pancreatic Surgery and Minimal Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China., Shen GL; General Surgery, Cancer Center, Department of Hepatobiliary and Pancreatic Surgery and Minimal Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China., Liu JW; General Surgery, Cancer Center, Department of Hepatobiliary and Pancreatic Surgery and Minimal Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China., Huang DS; General Surgery, Cancer Center, Department of Hepatobiliary and Pancreatic Surgery and Minimal Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.; Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Hangzhou, Zhejiang, China.; Department of Clinical Medicine, Hangzhou Medical College, Hangzhou, Zhejiang, China., Zhang CW; General Surgery, Cancer Center, Department of Hepatobiliary and Pancreatic Surgery and Minimal Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China., Liang L; General Surgery, Cancer Center, Department of Hepatobiliary and Pancreatic Surgery and Minimal Invasive Surgery, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou, Zhejiang, China.; Key Laboratory of Tumor Molecular Diagnosis and Individualized Medicine of Zhejiang Province, Hangzhou, Zhejiang, China.

المصدر: Expert review of gastroenterology & hepatology [Expert Rev Gastroenterol Hepatol] 2023 Apr; Vol. 17 (4), pp. 395-403. Date of Electronic Publication: 2023 Mar 20.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101278199 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1747-4132 (Electronic) Linking ISSN: 17474124 NLM ISO Abbreviation: Expert Rev Gastroenterol Hepatol Subsets: MEDLINE

مواضيع طبية MeSH: Carcinoma, Hepatocellular*/pathology , Liver Neoplasms*/pathology , Chemoembolization, Therapeutic*/methods, Humans ; Hepatectomy/adverse effects ; Retrospective Studies ; Neoplasm Recurrence, Local/pathology

المؤلفون: Bajracharya R; College of Pharmacy, Dongguk University-Seoul, Goyang, Korea., Song JG; College of Pharmacy, Dongguk University-Seoul, Goyang, Korea., Patil BR; College of Pharmacy, Dongguk University-Seoul, Goyang, Korea., Lee SH; College of Pharmacy, Dongguk University-Seoul, Goyang, Korea., Noh HM; College of Pharmacy, Dongguk University-Seoul, Goyang, Korea., Kim DH; College of Pharmacy, Dongguk University-Seoul, Goyang, Korea., Kim GL; College of Pharmacy, Dongguk University-Seoul, Goyang, Korea., Seo SH; College of Pharmacy, Dongguk University-Seoul, Goyang, Korea., Park JW; College of Pharmacy, Dongguk University-Seoul, Goyang, Korea., Jeong SH; College of Pharmacy, Dongguk University-Seoul, Goyang, Korea., Lee CH; College of Pharmacy, Dongguk University-Seoul, Goyang, Korea., Han HK; College of Pharmacy, Dongguk University-Seoul, Goyang, Korea.

المصدر: Drug delivery [Drug Deliv] 2022 Dec; Vol. 29 (1), pp. 1959-1970.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9417471 Publication Model: Print Cited Medium: Internet ISSN: 1521-0464 (Electronic) Linking ISSN: 10717544 NLM ISO Abbreviation: Drug Deliv Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents* , Quality of Life*, Drug Delivery Systems ; Humans ; Ligands ; Pharmaceutical Preparations

المؤلفون: Shen X; Department of Experimental Hematology and Biochemistry, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, China., Zhang L; Department of Experimental Hematology and Biochemistry, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, China.; Department of Clinical Laboratory, The General Hospital of PLA Rocket Force, Beijing, China., Xing S; Department of Experimental Hematology and Biochemistry, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, China., Zhang XW; Department of Experimental Hematology and Biochemistry, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, China., Xiong GL; Department of Experimental Hematology and Biochemistry, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, China., Cong YW; Department of Experimental Hematology and Biochemistry, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, China., Xiao H; Department of Molecular Immunology, Institute of Pharmacology and Toxicology, Beijing, China., Wang XR; Department of Clinical Laboratory, The General Hospital of PLA Rocket Force, Beijing, China., Yu ZY; Department of Experimental Hematology and Biochemistry, Beijing Key Laboratory for Radiobiology, Beijing Institute of Radiation Medicine, Beijing, China.; School of Life Science, Anhui Medical University, Hefei, China.

المصدر: Leukemia & lymphoma [Leuk Lymphoma] 2022 May; Vol. 63 (5), pp. 1202-1210. Date of Electronic Publication: 2021 Dec 08.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

مواضيع طبية MeSH: Antineoplastic Agents*/pharmacology , Antineoplastic Agents*/therapeutic use , Leukemia, Myeloid, Acute*/drug therapy, Cell Differentiation ; Enzyme Inhibitors/pharmacology ; Humans ; Pyrimidines/pharmacology ; Pyrimidines/therapeutic use ; Strobilurins/pharmacology ; Strobilurins/therapeutic use ; Tretinoin/pharmacology

المؤلفون: Wang FY; Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China., Wei GL; Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China., Fan YF; Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China., Zhao DF; Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China., Wang P; Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China., Zou LW; Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China., Yang L; Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.

المصدر: Journal of enzyme inhibition and medicinal chemistry [J Enzyme Inhib Med Chem] 2021 Dec; Vol. 36 (1), pp. 1079-1087.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101150203 Publication Model: Print Cited Medium: Internet ISSN: 1475-6374 (Electronic) Linking ISSN: 14756366 NLM ISO Abbreviation: J Enzyme Inhib Med Chem Subsets: MEDLINE

مواضيع طبية MeSH: Biological Products/*pharmacology , Catechol O-Methyltransferase/*metabolism , Enzyme Inhibitors/*pharmacology , Pentacyclic Triterpenes/*pharmacology, Biological Products/chemical synthesis ; Biological Products/chemistry ; Cell Survival/drug effects ; Cells, Cultured ; Dose-Response Relationship, Drug ; Enzyme Inhibitors/chemical synthesis ; Enzyme Inhibitors/chemistry ; Humans ; Kinetics ; Membrane Potential, Mitochondrial/drug effects ; Molecular Conformation ; Molecular Docking Simulation ; Pentacyclic Triterpenes/chemical synthesis ; Pentacyclic Triterpenes/chemistry ; Recombinant Proteins/metabolism ; Stereoisomerism ; Structure-Activity Relationship

المؤلفون: Song GL; Department of Oncology, People's Hospital of Yuechi County, Yuechi County, Sichuan Province, China., Xiao M; Department of Pathology, Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing, China., Wan XY; Department of Oncology, People's Hospital of Yuechi County, Yuechi County, Sichuan Province, China., Deng J; Department of Oncology, People's Hospital of Yuechi County, Yuechi County, Sichuan Province, China., Ling JD; Department of Oncology, People's Hospital of Yuechi County, Yuechi County, Sichuan Province, China., Tian YG; Department of Oncology, People's Hospital of Yuechi County, Yuechi County, Sichuan Province, China., Li M; Department of Oncology, People's Hospital of Yuechi County, Yuechi County, Sichuan Province, China., Yin J; Department of Oncology, People's Hospital of Yuechi County, Yuechi County, Sichuan Province, China., Zheng RY; Department of Oncology, People's Hospital of Yuechi County, Yuechi County, Sichuan Province, China., Tang Y; Department of Pathology, Molecular Medicine and Cancer Research Center, Chongqing Medical University, Chongqing, China., Liu GY; Department of General Surgery, The Affiliated Hospital of Chongqing Three Gorges, Chongqing, China.

المصدر: Bioengineered [Bioengineered] 2021 Dec; Vol. 12 (1), pp. 8407-8418.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101581063 Publication Model: Print Cited Medium: Internet ISSN: 2165-5987 (Electronic) Linking ISSN: 21655979 NLM ISO Abbreviation: Bioengineered Subsets: MEDLINE

مواضيع طبية MeSH: Down-Regulation*, Colorectal Neoplasms/*pathology , MicroRNAs/*genetics , Wnt1 Protein/*genetics, 3' Untranslated Regions ; Animals ; Cell Line, Tumor ; Cell Movement ; Cell Proliferation ; Colorectal Neoplasms/genetics ; Cyclin D1/genetics ; Female ; Gene Expression Regulation, Neoplastic ; HCT116 Cells ; Humans ; Mice ; Neoplasm Transplantation ; Proto-Oncogene Proteins c-myc/genetics

المؤلفون: Wu ZW; Hebei Province Center for Disease Control and Prevention, Shijiazhuang, People's Republic of China., Li QL; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China., Zhou HS; Zhengding County Center for Disease Control and Prevention, Zhengding, People's Republic of China., Duan K; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China., Gao Z; Hebei Province Center for Disease Control and Prevention, Shijiazhuang, People's Republic of China., Zhang XJ; Zhengding County Center for Disease Control and Prevention, Zhengding, People's Republic of China., Jiang ZJ; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China., Hao ZY; Zhengding County Center for Disease Control and Prevention, Zhengding, People's Republic of China., Jin F; Hebei Province Center for Disease Control and Prevention, Shijiazhuang, People's Republic of China., Bai X; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China., Li Q; Hebei Province Center for Disease Control and Prevention, Shijiazhuang, People's Republic of China., Xu GL; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China., Zhao YL; Hebei Province Center for Disease Control and Prevention, Shijiazhuang, People's Republic of China., Yang XM; Wuhan Institute of Biological Products Co., Ltd., Wuhan, People's Republic of China.

المصدر: Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2021 Jul 03; Vol. 17 (7), pp. 2311-2318. Date of Electronic Publication: 2021 Feb 05.

نوع المنشور: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE

مواضيع طبية MeSH: Rotavirus* , Rotavirus Infections*/prevention & control , Rotavirus Vaccines*/adverse effects, Adult ; Antibodies, Viral ; China ; Double-Blind Method ; Humans ; Immunogenicity, Vaccine ; Infant ; Vaccines, Attenuated/adverse effects ; Vaccines, Combined

المؤلفون: Xie GL; College of Life Science, Northeast Agricultural University, Harbin, China., Ma XR; College of Life Science, Northeast Agricultural University, Harbin, China.; State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China., Liu QY; State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China., Meng FX; State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China., Li C; State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China., Wang J; State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China., Guo YH; State Key Laboratory of Infectious Disease Prevention and Control, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China.

المصدر: Mitochondrial DNA. Part B, Resources [Mitochondrial DNA B Resour] 2021 Apr 15; Vol. 6 (4), pp. 1411-1415. Date of Electronic Publication: 2021 Apr 15 (Print Publication: 2021).

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101676334 Publication Model: eCollection Cited Medium: Internet ISSN: 2380-2359 (Electronic) Linking ISSN: 23802359 NLM ISO Abbreviation: Mitochondrial DNA B Resour Subsets: PubMed not MEDLINE

المؤلفون: Wu SH; He-Nan University of Chinese Medicine, Zheng-Zhou, China., Li HB; He-Nan University of Chinese Medicine, Zheng-Zhou, China., Li GL; Basic Medical College, He-Nan University of Chinese Medicine, Zheng-Zhou, China., Qi YJ; He-Nan University of Chinese Medicine, Zheng-Zhou, China., Zhang J; Basic Medical College, He-Nan University of Chinese Medicine, Zheng-Zhou, China., Wang BY; Basic Medical College, He-Nan University of Chinese Medicine, Zheng-Zhou, China.

المصدر: Pharmaceutical biology [Pharm Biol] 2020 Dec; Vol. 58 (1), pp. 374-384.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 9812552 Publication Model: Print Cited Medium: Internet ISSN: 1744-5116 (Electronic) Linking ISSN: 13880209 NLM ISO Abbreviation: Pharm Biol Subsets: MEDLINE

مواضيع طبية MeSH: Panax* , Plant Leaves* , Plant Roots*, Mitochondria/*drug effects , Plant Extracts/*pharmacology , Thermogenesis/*drug effects, Animals ; Energy Metabolism/drug effects ; Energy Metabolism/physiology ; Male ; Mice ; Mice, Inbred ICR ; Mitochondria/metabolism ; Plant Extracts/isolation & purification ; Thermogenesis/physiology